What type of study is this?

This is a In Vitro Study study.

December 4, 2025Scientific ReportsOpen Access

Ferulic acid-loaded chitosan nanoparticles enhance radiotherapy efficacy via STAT3 suppression and caspase-8/p53 activation in Ehrlich ascites carcinoma

View Full Paper

Ask AI

Bookmark

Ferulic acid nanoparticles improved tumor progression, achieving a 44.3% reduction in mass.
Tumor volume saw a 67.0% reduction with combination therapy, enhancing radiotherapy efficacy.
Observational analysis showed significant modulation of inflammatory cytokines and antitumor effects.
These findings highlight the potential of using targeted nanoparticles for improved cancer treatment.

No takes yet. Share an insight, caveat, or question.

Combination therapy improves tumor progression and inflammatory cytokines in Ehrlich ascites carcinoma, suggesting enhanced radiotherapy outcomes.

Mansour et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Combination therapy improves tumor progression and inflammatory cytokines in Ehrlich ascites carcinoma, suggesting enhanced radiotherapy outcomes.